Immunological detection of pyrazine-2-carboxylic acid for the detection of pyrazinamide resistance in Mycobacterium tuberculosis
- PMID: 33151985
- PMCID: PMC7643994
- DOI: 10.1371/journal.pone.0241600
Immunological detection of pyrazine-2-carboxylic acid for the detection of pyrazinamide resistance in Mycobacterium tuberculosis
Erratum in
-
Correction: Immunological detection of pyrazine-2-carboxylic acid for the detection of pyrazinamide resistance in Mycobacterium tuberculosis.PLoS One. 2021 Oct 27;16(10):e0259439. doi: 10.1371/journal.pone.0259439. eCollection 2021. PLoS One. 2021. PMID: 34705897 Free PMC article.
Abstract
Pyrazinamide (PZA) susceptibility testing in Mycobacterium tuberculosis (Mtb) is a current area of development and PZA-resistant strains are increasingly prevalent. Previous studies have demonstrated that the detection of pyrazinoic acid (POA), the metabolite produced by the deamidation of PZA, is a good predictor for PZA resistance since a resistant strain would not convert PZA into POA at a critical required rate, whereas a susceptible strain will do, expelling POA to the extracellular environment at a certain rate, and allowing for quantification of this accumulated analyte. In order to quantify POA, an indirect competitive ELISA (icELISA) test using hyperimmune polyclonal rabbit serum against POA was developed: for this purpose, pure POA was first covalently linked to the highly immunogenic Keyhole Limpet Hemocyanine, and inoculated in rabbits. A construct made of bovine serum albumin (BSA) linked to pure POA and fixed at the bottom of wells was used as a competitor against spiked samples and liquid Mtb culture supernatants. When spiked samples (commercial POA alone) were analyzed, the half maximal inhibitory concentration (IC50) was 1.16 mg/mL, the limit of detection 200 μg/mL and the assay was specific (it did not detect PZA, IC50 > 20 mg/mL). However, culture supernatants (7H9-OADC-PANTA medium) disrupted the competition and a proper icELISA curve was not obtainable. We consider that, although we have shown that it is feasible to induce antibodies against POA, matrix effects could damage its analytical usefulness; multiple, upcoming ways to solve this obstacle are suggested.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures





Similar articles
-
Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide.J Med Microbiol. 2002 Jan;51(1):42-49. doi: 10.1099/0022-1317-51-1-42. J Med Microbiol. 2002. PMID: 11800471
-
pncA gene expression and prediction factors on pyrazinamide resistance in Mycobacterium tuberculosis.Tuberculosis (Edinb). 2013 Sep;93(5):515-22. doi: 10.1016/j.tube.2013.03.005. Epub 2013 Jul 16. Tuberculosis (Edinb). 2013. PMID: 23867321 Free PMC article.
-
A novel inexpensive electrochemical sensor for pyrazinoic acid as a potential tool for the identification of pyrazinamide-resistant Mycobacterium tuberculosis.Int J Mycobacteriol. 2018 Jul-Sep;7(3):275-281. doi: 10.4103/ijmy.ijmy_63_18. Int J Mycobacteriol. 2018. PMID: 30198510
-
Pyrazinamide: the importance of uncovering the mechanisms of action in mycobacteria.Expert Rev Anti Infect Ther. 2015 May;13(5):593-603. doi: 10.1586/14787210.2015.1021784. Epub 2015 Mar 6. Expert Rev Anti Infect Ther. 2015. PMID: 25746054 Review.
-
Pyrazinamide and Pyrazinoic Acid Derivatives Directed to Mycobacterial Enzymes Against Tuberculosis.Curr Protein Pept Sci. 2016;17(3):213-9. doi: 10.2174/1389203716666151002114839. Curr Protein Pept Sci. 2016. PMID: 26427385 Review.
Cited by
-
Correction: Immunological detection of pyrazine-2-carboxylic acid for the detection of pyrazinamide resistance in Mycobacterium tuberculosis.PLoS One. 2021 Oct 27;16(10):e0259439. doi: 10.1371/journal.pone.0259439. eCollection 2021. PLoS One. 2021. PMID: 34705897 Free PMC article.
-
A simplified pyrazinamidase test for Mycobacterium tuberculosis pyrazinamide antimicrobial susceptibility testing.J Clin Microbiol. 2024 Dec 11;62(12):e0122724. doi: 10.1128/jcm.01227-24. Epub 2024 Nov 18. J Clin Microbiol. 2024. PMID: 39555932 Free PMC article.
References
-
- WHO. Global Tuberculosis Report. Geneva: World Health Organization, 2018.
-
- Girum T, Muktar E, Lentiro K, Wondiye H, Shewangizaw M. Epidemiology of multidrug-resistant tuberculosis (MDR-TB) in Ethiopia: a systematic review and meta-analysis of the prevalence, determinants and treatment outcome. Trop Dis Travel Med Vaccines. 2018;4:5 Epub 2018/06/27. 10.1186/s40794-018-0065-5 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical